These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10098550)

  • 21. Laboratory examination of the thyroid. 1. In vitro tests.
    Schneider PB
    Postgrad Med; 1974 Aug; 56(2):91-6. PubMed ID: 4136847
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
    Molnár I; Balázs C
    Acta Med Hung; 1991; 48(1-2):13-21. PubMed ID: 1813853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computerized tomography in Graves' immunoophthalmopathy.
    Sowiński J; Ziemiański A; Gembicki M
    Radiobiol Radiother (Berl); 1984; 25(5):749-54. PubMed ID: 6548825
    [No Abstract]   [Full Text] [Related]  

  • 24. Thyrotropin-releasing hormone (a test to diagnose Graves' ophthalmopathy).
    Hyman BN; Johnson PC
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1975; 79(3 Pt 2):OP524-8. PubMed ID: 50663
    [No Abstract]   [Full Text] [Related]  

  • 25. [Computerized tomography in patients with Graves-Basedow disease treated with radioactive iodine (I-131)].
    Sowiński J; Ziemiański A; Gembicki M
    Endokrynol Pol; 1984; 35(3):165-72. PubMed ID: 6548700
    [No Abstract]   [Full Text] [Related]  

  • 26. Graves' disease of the orbit.
    Weber AL; Dallow RL; Sabates NR
    Neuroimaging Clin N Am; 1996 Feb; 6(1):61-72. PubMed ID: 8919134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computerized tomography in endocrine exophthalmos: report of a case.
    Solomon A; Rieder-Grosswasser I; Feiler-Ofry V; Lazar M; Greenwald M
    Ann Ophthalmol; 1982 Feb; 14(2):191-3. PubMed ID: 6896413
    [No Abstract]   [Full Text] [Related]  

  • 28. [Computed tomography of the dysthyroid ophthalmopathy (author's transl)].
    Yagishita A; Shiga I; Suzuki S; Tsutsui T; Nishioka K; Ichikizaki K; Kimura T; Inoue Y; Ito K; Ban Y
    Rinsho Hoshasen; 1978 Jul; 23(7):741-5. PubMed ID: 580942
    [No Abstract]   [Full Text] [Related]  

  • 29. Presumed scleral perforation during forced duction testing of the superior oblique muscle.
    Kassem RR
    J AAPOS; 2011 Jun; 15(3):291-2. PubMed ID: 21641248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Computerized tomography of the orbit in Graves-Basedow disease].
    Krzystolikowa Z; Daniel B; Przerwa D; Pilarska K
    Klin Oczna; 1984 Nov; 86(11):481-3. PubMed ID: 6549522
    [No Abstract]   [Full Text] [Related]  

  • 31. Neonatal hypothyroxinemia with normal thyrotropin. Clue to maternal Graves' disease.
    Slyper AH; Shaker JL
    Clin Pediatr (Phila); 1993 Feb; 32(2):121-3. PubMed ID: 8094332
    [No Abstract]   [Full Text] [Related]  

  • 32. Graves' disease: diagnostic and therapeutic challenges (multimedia activity).
    Kahaly GJ; Grebe SK; Lupo MA; McDonald N; Sipos JA
    Am J Med; 2011 Jun; 124(6):S2-3. PubMed ID: 21605717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of computerized tomography in the diagnosis of orbital changes in Graves-Basedow disease].
    Ziemiański A; Sowiński J; Sosnowski P
    Pol Przegl Radiol; 1983; 47(5-6):349-54. PubMed ID: 6379608
    [No Abstract]   [Full Text] [Related]  

  • 34. Appearance of Graves' disease on orbital computed tomography.
    Enzmann DR; Donaldson SS; Kriss JP
    J Comput Assist Tomogr; 1979 Dec; 3(6):815-9. PubMed ID: 583152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities.
    Kuzuya N; Chiu SC; Ikeda H; Uchimura H; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1979 Apr; 48(4):706-11. PubMed ID: 581876
    [No Abstract]   [Full Text] [Related]  

  • 36. Dysthyroid ophthalmopathy.
    Kelman SE; Karesh JW
    Am Fam Physician; 1986 Jul; 34(1):167-78. PubMed ID: 3755279
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability of estimating ductions in thyroid eye disease: an International Thyroid Eye Disease Society multicenter study.
    Dolman PJ; Cahill K; Czyz CN; Douglas RS; Elner VM; Feldon S; Kazim M; Lucarelli M; Sivak-Collcott J; Stacey AW; Strianese D; Uddin J
    Ophthalmology; 2012 Feb; 119(2):382-9. PubMed ID: 21959369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Toxic adenoma of the thyroid gland].
    Schneck O; Eber O; Wascher H
    Wien Z Inn Med; 1966 Jul; 47(7):261-77. PubMed ID: 4187164
    [No Abstract]   [Full Text] [Related]  

  • 40. Graves thyrotoxicosis following primary thyroid failure.
    Bremner WJ; Griep RJ
    JAMA; 1976 Mar; 235(13):1361. PubMed ID: 946257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.